N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization

Med Microbiol Immunol. 2006 Sep;195(3):165-72. doi: 10.1007/s00430-006-0016-z. Epub 2006 Mar 18.

Abstract

Here we report that N-glycans within the V1/V2 variable regions of the NL4-3 gp120 glycoprotein are indispensable to maintain viral functionality and are masking neutralizing epitopes. Fifteen variants of HIV-1 isolate NL4-3 with mutations of the six N-glycosylation sites g2-g7 within the V1 (g2-g4) and V2 loop (g5-g7) of gp120 were analyzed for viral infectivity and their sensitivity to neutralization. Presence of the N-glycans g4, g5, g6 and g7 was an important prerequisite to maintain viral infectivity, since virus mutants lacking these N-glycans were highly deficient in virus entry. Lack of g4 or g7 correlated to a reduction of infectivity to less than 3% of the infectivity observed for NL4-3 wild type. In contrast, mutants lacking N-glycans g2 and g3 showed a 50% increase in infectivity compared to NL4-3. Mutants lacking g2, g3, g5 and g6 with an infectivity of more than 10% of the NL4-3 wt virus were tested for neutralization and showed a high sensitivity against human serum antibody from HIV-1 infected individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Antibodies / immunology
  • HIV Envelope Protein gp120 / chemistry
  • HIV Envelope Protein gp120 / physiology*
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • HIV-1 / pathogenicity
  • HeLa Cells
  • Humans
  • Neutralization Tests
  • Polysaccharides / physiology*

Substances

  • HIV Antibodies
  • HIV Envelope Protein gp120
  • Polysaccharides